As of 2025-08-11, the Intrinsic Value of Merck KGaA (MRK.DE) is 88.62 EUR. This MRK.DE valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 108.10 EUR, the upside of Merck KGaA is -18.00%.
The range of the Intrinsic Value is 62.64 - 145.37 EUR
Based on its market price of 108.10 EUR and our intrinsic valuation, Merck KGaA (MRK.DE) is overvalued by 18.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 62.64 - 145.37 | 88.62 | -18.0% |
| DCF (Growth 10y) | 80.34 - 172.70 | 109.58 | 1.4% |
| DCF (EBITDA 5y) | 89.26 - 151.64 | 126.05 | 16.6% |
| DCF (EBITDA 10y) | 103.79 - 177.30 | 144.19 | 33.4% |
| Fair Value | 124.81 - 124.81 | 124.81 | 15.46% |
| P/E | 144.04 - 178.19 | 161.06 | 49.0% |
| EV/EBITDA | 90.28 - 163.12 | 127.38 | 17.8% |
| EPV | 100.25 - 139.09 | 119.67 | 10.7% |
| DDM - Stable | 52.55 - 144.72 | 98.63 | -8.8% |
| DDM - Multi | 67.02 - 144.37 | 91.64 | -15.2% |
| Market Cap (mil) | 46,999.72 |
| Beta | 0.77 |
| Outstanding shares (mil) | 434.78 |
| Enterprise Value (mil) | 54,684.72 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.33% |
| Cost of Debt | 5.00% |
| WACC | 7.54% |